Targeted integration of adeno-associated virus-derived plasmids in transfected human cells

Virology

Volumn 249, Issue 2, 1998, Pages 249-259

  Pieroni, Luisa ^a   Fipaldini, Cristina ^a   Monciotti, Andrea ^a   Cimini, Daniela ^b   Sgura, Antonella ^b   Fattori, Elena ^a   Epifano, Olga ^a   Cortese, Riccardo ^a   Palombo, Fabio ^a   La Monica, Nicola ^a  

^a IRBM   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS; ARTICLE; CHROMOSOME 19; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; VIRUS DNA CELL DNA INTERACTION;

EID: 0032581938     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9332     Document Type: Article

References (54)

1. Afione G. A., Conrad C. K., Kearns W. G., Chunduru S., Adams R., Reynolds T. C., Guggino W. B., Cutting G. R., Carter B. J., Flotte T. R. In vivo model of adeno-associated virus vector persistence and rescue. J. Virol. 70:1996;3235-3241.
2. Ashktorab H., Srivastava A. Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA. J. Virol. 63:1989;3034-3039.
3. Balagué C., Kalla M., Zhang W. W. Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J. Virol. 71:1997;3299-3306.
4. Berns K. I. Parvoviridae: the viruses and their replication. Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 2173-2197.
5. Bukder V., Zhang G., Knechtle S., Wolff J. A. Naked DNA delivered intraportally expresses efficiently in hepatocytes. Gene Ther. 3:1996;593-598.
6. Chalfie M., Tu Y., Euskirchen G., Ward W. W., Prasher D. C. Green fluorescent protein as a marker for gene expression. Science. 263:1994;802-805.
7. Fisher K. J., Joos K., Alston J., Yang Y., Haecker S. E., High K., Pathak R. S., Raper E., Wilson J. M. Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3:1997;306-312.
8. Flotte T. R., Afione S. A., Zeitlin P. L. Adeno-associated virus vector gene expression occurs in non-dividing cells in the absence of vector DNA integration. J. Respir. Cell. Mol. Biol. 11:1994;517-521.
9. Giraud C., Winocour E., Bernks K. I. Site-specific integration by adeno-associated virus is directed by a cellular sequence. Proc. Natl. Acad. Sci. USA. 91:1994;10039-10043.
10. Goodman S., Xiao X., Donahue R. E., Moulton A., Miller J., Walsh C., Young N. S., Samulski R. J., Nienhuis A. W. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood. 84:1994;1492-1500.
11. Heilbronn R., Bürkle A., Stephan S., zur Hausen H. The adeno-associated virusrep. J. Virol. 64:1990;3012-3018.
12. Hermonat P. L., Batchu R. B. The adeno-associated virus Rep78 major regulatory protein forms multimeric complexes and the domain for this activity is contained within the carboxy-half of the molecule. FEBS Lett. 401:1997;180-184.
13. Hermonat P. L., Muzyczka N. Use of an adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into a mammalian tissue culture cells. Proc. Natl. Acad. USA. 81:1984;6466-6470.
14. Hirt B. Selective extraction of polyoma DNA from infected mouse cultures. J. Mol. Biol. 26:1967;365-369.
15. Hörer M., Weger S., Butz K., Hoppe-Seyler F., Geisen C., Kleidschmidt J. A. Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. J. Virol. 69:1995;5485-5496.
16. Im D. S., Mucyczka N. Factors that bind to adeno-associated virus terminal repeats. J. Virol. 63:1989;3095-3104.
17. Im D. S., Mucyczka N. The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell. 61:1990;447-457.
18. Im D. S., Mucyczka N. Partial purification of adeno-associated virus Rep78, Rep68, Rep52, and Rep40 and their biochemical characterization. J. Virol. 66:1992;1119-1128.
19. Kapitt M. G., Leone P., Samulski R. J., Xiao X., Pfaff D. W., O'Malley K. L., During M. J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:1994;148-154.
20. Kearns W. G., Afione S. A., Fulmer S. B., Pang M. G., Erikson D., Egan M., Landrum M. J., Flotte T. R., Cutting G. R. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 3:1996;748-755.
21. Kessler P. D., Podsakoff G. M., Chen X., McQuiston S. A., Colosi P. C., Matelis L. A., Kurtzman G. J., Byrne B. J. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA. 93:1996;14082-14087.
22. Koeberl D. D., Alexander I. E., Halbert C. L., Russell D. W., Miller A. D. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA. 94:1997;1426-1431.
23. Kotin R. M., Berns K. I. Organization of adeno-associated virus DNA in latently infected Detroit 6 cell line. Virology. 170:1989;460-467.
24. Kotin R. M., Siniscalco M., Samulski R. J., Zhu X., Hunter L., Laughlin C. A., McLaughlin S., Muzyczka N., Rocchi M., Berns K. I. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA. 87:1990;2211-2215.
25. Kotin R. M., Linden R. M., Berns K. I. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11:1992;5071-5078.
26. LaFace D., Hermonat P., Wakeland E., Peck A. Gene transfer into hemapoietic progenitor cells mediated by an adeno-associated virus vector. Virology. 162:1988;483-486.
27. Lamartina S., Roscilli G., Rinaudo D., Delmastro P., Toniatti C. Lipofection of purified Adeno-associated virus Rep68 protein: toward a chrmosome-targeting non-viral particle. J. Virol. 72:1998;7653-7658.
28. Lawrence J. B., Villnave C. A., andSinger R. H. Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line. Cell. 52:1988;51-61.
29. Lebkowski J. S., Okarma T. B., Philip R. The challenges of recombinant adeno-associated virus manufacturing: alternative use of adeno-associated virus plasmid/liposome complexes for gene therapy applications. Curr. Topics Microb. Immunol. 218:1996;51-59.
30. Ledley F. D. Hepatic gene therapy: present and future. Hepatology. 18:1993;1263-1273.
31. Leonard C. J., Berns K. I. Adeno-associated virus type 2: a latent life cycle. Progr. Nucleic Acids Res. Mol. Biol. 48:1994;29-52.
32. Linden R. M., Winocour E., Berns K. I. The recombinationsignals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. USA. 93:1996;7966-7972.
33. McLaughlin S. K., Collis P., Hermonat P. L., Mucyczka N. Adeno-associated virus general transduction vectors: analysis of proviral structure. J. Virol. 62:1988;1963-1973.
34. Palombo F., Monciotti A., Recchia A., Cortese R., Ciliberto G., La Monica N. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J. Virol. 72:1998;5025-5034.
35. Philip R., Brunette E., Kilinski L., Murugesh D., McNally M. A., Ucar K., Rosenblatt J., Okarma T. B., Lebkowski J. S. Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol. Cell. Biol. 14:1994;2411-2418.
36. Ponnazhagan S., Erikson D., Kearns W. G., Zhou S. Z., Nahreini P., Wang X.-S., Srivastava A. Lack of site-specific integration of the adeno-associated virus 2 genomes in human cells. Hum. Gene Ther. 8:1997;275-284.
37. Reed Clark K., Sferra T. J., Johnson P. R. Recombinant aden-associated viral vectors mediate long-term transgene expression in muscle. Hum. Gene Ther. 8:1997;659-669.
38. Russel D. W., Miller A. D., Alexander I. E. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA. 91:1994;8915-8919.
39. Samulski R. J. Adeno-associated virus: integration at a specific chromosomal locus. Curr. Opin. Gen. Dev. 3:1993;74-80.
40. Samulski R. J., Berns K. I., Tan M., Mucyczka N. Cloning of AAV into pBR322: rescue of intact viruses from the recombinant plasmid into human cells. Proc. Natl. Acad. Sci. USA. 109:1982;2077-2081.
41. Samulski R. J., Chang L.-S., Shenk T. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61:1987;3096-3101.
42. Samulski R. J., Chang L.-S., Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:1989;3822-3828.
43. Samulski R. J., Zhu X., Xiao X., Brook J. D., Housman D. E., Epstein N., Hunter L. A. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10:1991;3941-3950.
44. Shelling A. N., Smith M. Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene. Gene Ther. 1:1994;165-169.
45. Snyder R. O., Samulski R. J., Mucyczka N. In vitro resolution of covalently joined AAV chromosome ends. Cell. 60:1990;105-113.
46. Srivastava A., Lubsy E. W., Berns K. I. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45:1983;555-564.
47. Surosky R. T., Urabe M., Godwin S. G., McQuiston S. A., Kurtzman G. J., Ozawa K., Natsoulis G. Adeno-asssociated virus Rep proteins target DNA sequences t a unique locus in the human genome. J. Virol. 71:1997;7951-7959.
48. Tratschin J.-D., Miller I. L., Smith M. G., Carter B. J. Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells. Mol. Cell. Biol. 5:1985;3251-3260.
49. Urcelay E., Ward P., Wiener S. M., Safer B., Kotin R. Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep proteins. J. Virol. 69:1995;2038-2046.
50. Waltz C., Shlehofer J. R. Modification of some biological properties of HeLa cells containing adeno-associated virus DNA integrated into chromosome 17. J. Virol. 66:1992;2990-3002.
51. Weitzman M. D., Kyöstiö S. R. M., Kotin R. M., Owens R. A. Adeno-associated virus (AAV) rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. USA. 91:1994;5808-5812.
52. Wobbe C. R., Dean F., Weissbach L., Hurwitz J. In vitro replication of duplex circular DNA containing the Simian virus 40 DNA origin site. Proc. Natl. Acad. Sci. USA. 81:1985;5710-5714.
53. Xiao X., Li J., Samulski R. J. Efficient gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:1996;8098-8108.
54. Yang C. C., Xiao X., Zhu X., Ansardi D. C., Epstein N. D., Frey M. R., Matera A. G., Samulski R. J. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J. Virol. 71:1997;9231-9247.